These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11698296)

  • 1. Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes.
    Gerber CE; Bruchelt G; Falk UB; Kimpfler A; Hauschild O; Kuçi S; Bächi T; Niethammer D; Schubert R
    Blood; 2001 Nov; 98(10):3097-105. PubMed ID: 11698296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated D-amino acid oxidase restores bactericidal activity of neutrophils in chronic granulomatous disease via hypochlorite.
    Nakamura H; Fang J; Mizukami T; Nunoi H; Maeda H
    Exp Biol Med (Maywood); 2012 Jun; 237(6):703-8. PubMed ID: 22715431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease.
    Fernandez-Boyanapalli RF; Frasch SC; Thomas SM; Malcolm KC; Nicks M; Harbeck RJ; Jakubzick CV; Nemenoff R; Henson PM; Holland SM; Bratton DL
    J Allergy Clin Immunol; 2015 Feb; 135(2):517-527.e12. PubMed ID: 25498313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypochlorous acid regulates neutrophil extracellular trap release in humans.
    Palmer LJ; Cooper PR; Ling MR; Wright HJ; Huissoon A; Chapple IL
    Clin Exp Immunol; 2012 Feb; 167(2):261-8. PubMed ID: 22236002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of liposomes for correction of the metabolic and bactericidal deficiencies in chronic granulomatous disease.
    Ismail G; Boxer LA; Baehner RL
    Pediatr Res; 1979 Jun; 13(6):769-73. PubMed ID: 481946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococci surviving intracellularly in phagocytes from patients suffering from chronic granulomatous disease are killed in vitro by antibiotics encapsulated in liposomes.
    Roesler J; Hockertz S; Vogt B; Lohmann-Matthes ML
    J Clin Invest; 1991 Oct; 88(4):1224-9. PubMed ID: 1918376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase is not required for spontaneous and Staphylococcus aureus-induced apoptosis of monocytes.
    v Bernuth H; Kulka C; Roesler J; Gahr M; Rösen-Wolff A
    Ann Hematol; 2004 Apr; 83(4):206-11. PubMed ID: 14730390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Pioglitazone Lead to Neutrophil Extracellular Traps Formation in Chronic Granulomatous Disease Patients?
    Hule GP; Bargir UA; Kulkarni M; Kambli P; Taur P; Desai M; Madkaikar MR
    Front Immunol; 2019; 10():1739. PubMed ID: 31428088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
    Wenger RH; Marti HH; Schuerer-Maly CC; Kvietikova I; Bauer C; Gassmann M; Maly FE
    Blood; 1996 Jan; 87(2):756-61. PubMed ID: 8555500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.
    Johnston RB; Keele BB; Misra HP; Lehmeyer JE; Webb LS; Baehner RL; RaJagopalan KV
    J Clin Invest; 1975 Jun; 55(6):1357-72. PubMed ID: 166094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases.
    Briggs RT; Karnovsky ML; Karnovsky MJ
    J Clin Invest; 1977 Jun; 59(6):1088-98. PubMed ID: 193872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p47phox mouse knock-out model of chronic granulomatous disease.
    Jackson SH; Gallin JI; Holland SM
    J Exp Med; 1995 Sep; 182(3):751-8. PubMed ID: 7650482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with Polyethylene Glycol-Conjugated Fungal D-Amino Acid Oxidase Reduces Lung Inflammation in a Mouse Model of Chronic Granulomatous Disease.
    Nunoi H; Xie P; Nakamura H; Aratani Y; Fang J; Nishimura T; Kataoka H; Maeda H; Matsukura M
    Inflammation; 2022 Aug; 45(4):1668-1679. PubMed ID: 35211862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease.
    Hartl D; Lehmann N; Hoffmann F; Jansson A; Hector A; Notheis G; Roos D; Belohradsky BH; Wintergerst U
    J Allergy Clin Immunol; 2008 Feb; 121(2):375-382.e9. PubMed ID: 18155283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of chronic granulomatous disease.
    Roos D; de Boer M
    Clin Exp Immunol; 2014 Feb; 175(2):139-49. PubMed ID: 24016250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease.
    Lekstrom-Himes JA; Kuhns DB; Alvord WG; Gallin JI
    J Immunol; 2005 Jan; 174(1):411-7. PubMed ID: 15611265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-formylpterin intracellularly generates hydrogen peroxide and restores the impaired bactericidal activity of human neutrophils.
    Yamashita K; Arai T; Fukuda K; Mori H; Ishii H; Nishioka M; Tajima K; Makino K; Sasada M
    Biochem Biophys Res Commun; 2001 Nov; 289(1):85-90. PubMed ID: 11708781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F
    Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.